Major equity averages turned mixed Wednesday, while yields jumped, as Wall Street assessed a hotter-than-anticipated monthly U.S. consumer inflation report. The Nasdaq Composite (COMP:IND) was up less ...

Below is Validea's guru fundamental report for HOME DEPOT INC (HD). Of the 22 guru strategies we follow, HD rates highest using our Multi-Factor Investor model based on the published strategy of ...

Below is Validea's guru fundamental report for HOME DEPOT INC (HD). Of the 22 guru strategies we follow, HD rates highest using our Multi-Factor Investor model based on the published strategy of ...

All three major stock indexes closed higher on Wednesday, rebounding from declines earlier in the session as investors ...

Invesco FTSE RAFI US 1500 Small-Mid ETF Trading Up 0.2 % Shares of NASDAQ:PRFZ opened at $43.35 on Friday. The company has a 50 day moving average of $42.88 and a 200-day moving average of $41.88.

Because the $103.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility ...

Deep-pocketed investors have adopted a bullish approach towards Nebius Group (NASDAQ:NBIS), and it's something ... interest is a powerful move while trading options. This data can help you track ...

ELECTRO TRADING, an importer and distributor serving ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...

Day trading -- the practice of buying and selling financial assets like stocks, options, or futures within the same trading day -- comes with a variety of advantages. It appeals to traders looking ...

(RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP), on Thursday, announced positive topline results from its Phase 1 single ascending dose trial of TNX-1500, being developed for the prevention ...